Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLID: Zemplar in chronic kidney disease and diabetic nephropathy
NCT01204528Phase 3Completed
- Sponsor
- Danderyds sjukhus
- Start
- Sep 2010
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of paricalcitol in chronic kidney disease (CKD), diabetic nephropathy (DN), sponsored by Danderyds sjukhus. Started Sep 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01204528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204528.